In conclusion, our results indicated that texture features derived from kinetic parameter maps, calculated based on breast DCE-MRI, have the potential to be used as imaging biomarkers for distinguishing HER2-positive and HER2-negative breast cancer. Here, ERBB2 is linked to breast cancer.